Related Experiment Video
Updated: Sep 27, 2025

06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
5.0K
Exploration of Ultralarge Compound Collections for Drug Discovery
Wendy A Warr1, Marc C Nicklaus2, Christos A Nicolaou3
1Wendy Warr & Associates, 6 Berwick Court, Holmes Chapel, Crewe, Cheshire CW4 7HZ, United Kingdom.
Journal of Chemical Information and Modeling
|April 14, 2022
Summary
Exploring vast chemical spaces using computational tools accelerates drug discovery. This review covers methods for navigating enormous chemical libraries and designing novel medicines efficiently.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Drug Discovery
Background:
- Drug design is limited by the vastness of chemical space.
- Advances in computing enable exploration of virtual chemical spaces.
- Efficiently searching and navigating these spaces is crucial for drug discovery.
Purpose of the Study:
- To review methods for exploring large chemical spaces.
- To discuss technologies for searching chemical libraries and combinatorial spaces.
- To explore novel approaches in de novo drug design and autonomous synthesis.
Main Methods:
- Review of computational tools and algorithms for chemical space navigation.
- Analysis of techniques for constructing and searching large chemical libraries.
- Discussion of emerging technologies in de novo drug design and automated synthesis.
Main Results:
- Billions of chemical structures can be navigated computationally.
- New technologies enhance searching of huge and combinatorial chemical spaces.
- Autonomous laboratories show potential for synthesizing designed compounds.
Conclusions:
- Computational exploration of chemical space is key to faster, cheaper drug design.
- Advanced search and navigation techniques are vital for drug discovery.
- Future drug design will likely involve autonomous laboratories and novel de novo approaches.
Related Concept Videos
Drug Discovery: Overview
9.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.0K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K

